Samit Hirawat

Insider Reports History

Entity
Individual
Location
Bristol Myers Sqiubb Company, Route 206 & Province Line Road, Princeton, NJ
Signature
/s/ Lisa A. Atkins, attorney-in-fact for Samit Hirawat
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samit Hirawat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Common Stock, $0.10 par value 79.3K $5M $63.11 Mar 10, 2025 Direct
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Common Stock, $0.10 par value 60.3K $3.24M $53.79 Mar 10, 2024 Direct
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Market Share Units 35.1K $1.86M $52.99 Mar 10, 2025 Direct
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Performance Shares 52.7K Mar 10, 2025 Direct

Insider Reports Filed by Samit Hirawat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2025 18 -$1.01M 4 Mar 12, 2025 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Feb 14, 2025 1 $100K 4 Feb 19, 2025 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Nov 1, 2024 1 $100K 4 Nov 5, 2024 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2024 16 -$734K 4 Mar 12, 2024 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Jul 1, 2023 3 -$306K 4 Jul 5, 2023 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2023 18 -$1.47M 4 Mar 14, 2023 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Jul 1, 2022 3 -$368K 4 Jul 5, 2022 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2022 10 -$356K 4 Mar 14, 2022 EVP,Chief Med.Offr.,Drug Dev.
BMY BRISTOL MYERS SQUIBB CO Jul 1, 2021 3 -$319K 4 Jul 6, 2021 EVP,Chief Med.Offr.,Drug Dev.